A Review on the Effectivity of the Current COVID-19 Drugs and Vaccines: Are They Really Working Against the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Variants?-Reference-Cited by-同舟云学术

A Review on the Effectivity of the Current COVID-19 Drugs and Vaccines: Are They Really Working Against the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Variants?

Published:2021-07-03 Issue:3 Volume:8 Page:186-193
ISSN:2196-5471
Container-title:Current Clinical Microbiology Reports
language:en
Short-container-title:Curr Clin Micro Rpt

Author:

Noor Rashed^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Infectious Diseases,Microbiology (medical)

Link

https://link.springer.com/content/pdf/10.1007/s40588-021-00172-w.pdf

Reference36 articles.

1. Noor R, Maniha SM. A brief outline of respiratory viral disease outbreaks: 1889 – till date on the public health perspectives. Virus Dis. 2020;31:441–9. https://doi.org/10.1007/s13337-020-00628-5.

2. Noor R. Developmental status of the potential vaccines for the mitigation of the COVID-19 pandemic and a focus on the effectiveness of the Pfizer-BioNTech and Moderna mRNA vaccines. Curr Clin Microbiol Rep. 2021. https://doi.org/10.1007/s40588-021-00162-y.

3. •• Noor R. A comparative review of pathogenesis and host innate immunity evasion strategies among the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), severe acute respiratory syndrome coronavirus (SARS-CoV) and the Middle East respiratory syndrome coronavirus (MERS-CoV). Arch Microbiol. 2021. https://doi.org/10.1007/s00203-021-02265-y This study provides a thorough description of the molecular aspects of pathogenesis of SARS-CoV-2, SARS-CoV and MERS-CoV. Since the viral entry is the first step of pathogenesis, a distinctive explanation about the viral spike protein-host receptors is given.

4. Asaduzzaman SAI, Zakaria A, Kheya IS, Fahad N, Sikandar YB, Noor R. A comparative study between the severe acute respiratory syndrome-coronavirus-2, severe acute respiratory syndrome coronavirus, and the Middle East respiratory syndrome coronavirus. Biomed Biotechnol Res J. 2020;4:S65–74. https://doi.org/10.4103/bbrj.bbrj_99_20.

5. Wrapp D, Wang N, Corbett KS, Goldsmith JA, Hsieh CL, Abiona O, et al. Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation. Science. 2020;367(6483):1260–3. https://doi.org/10.1126/science.abb2507.

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Structural Insights into SARS-CoV-2 Nonstructural Protein 1 Interaction with Human Cyclophilin and FKBP1 to Regulate Interferon Production;The Journal of Physical Chemistry Letters;2024-01-19

2. Novel SARS‐CoV‐2 entry inhibitors, 2‐anilinoquinazolin‐4(3H)‐one derivatives, show potency as SARS‐CoV‐2 antivirals in a human ACE2 transgenic mouse model;Journal of Medical Virology;2023-06

3. The Potential Role of Medicinal Plants, Traditional Herbal Medicines, and Formulations to Overcome SARS-CoV-2 Induced Health Crisis;Sustainable Development and Biodiversity;2023

4. Structural analysis of a simplified model reproducing SARS-CoV-2 S RBD/ACE2 binding site;Heliyon;2022-11

5. The Advantage of Using Immunoinformatic Tools on Vaccine Design and Development for Coronavirus;Vaccines;2022-10-31